PL2066300T5 - Samokonserwujące wodne kompozycje farmaceutyczne - Google Patents

Samokonserwujące wodne kompozycje farmaceutyczne

Info

Publication number
PL2066300T5
PL2066300T5 PL07842925T PL07842925T PL2066300T5 PL 2066300 T5 PL2066300 T5 PL 2066300T5 PL 07842925 T PL07842925 T PL 07842925T PL 07842925 T PL07842925 T PL 07842925T PL 2066300 T5 PL2066300 T5 PL 2066300T5
Authority
PL
Poland
Prior art keywords
self
pharmaceutical compositions
aqueous pharmaceutical
preserved aqueous
preserved
Prior art date
Application number
PL07842925T
Other languages
English (en)
Other versions
PL2066300T3 (pl
Inventor
Masood A. Chowhan
David J. Keith
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39144554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2066300(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2066300T3 publication Critical patent/PL2066300T3/pl
Publication of PL2066300T5 publication Critical patent/PL2066300T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL07842925T 2006-09-28 2007-09-20 Samokonserwujące wodne kompozycje farmaceutyczne PL2066300T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82741706P 2006-09-28 2006-09-28
PCT/US2007/079094 WO2008042619A2 (en) 2006-09-28 2007-09-20 Self-preserved aqueous pharmaceutical compositions
EP07842925.5A EP2066300B2 (en) 2006-09-28 2007-09-20 Self-preserved aqueous pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PL2066300T3 PL2066300T3 (pl) 2015-10-30
PL2066300T5 true PL2066300T5 (pl) 2020-03-31

Family

ID=39144554

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07842925T PL2066300T5 (pl) 2006-09-28 2007-09-20 Samokonserwujące wodne kompozycje farmaceutyczne

Country Status (14)

Country Link
US (1) US8388941B2 (pl)
EP (1) EP2066300B2 (pl)
JP (2) JP5394927B2 (pl)
KR (1) KR101421519B1 (pl)
CN (1) CN101522171A (pl)
AU (1) AU2007304996B2 (pl)
BR (1) BRPI0717093A2 (pl)
CA (1) CA2663817A1 (pl)
ES (1) ES2543349T5 (pl)
HK (1) HK1126419A1 (pl)
MX (1) MX2009003042A (pl)
PL (1) PL2066300T5 (pl)
WO (1) WO2008042619A2 (pl)
ZA (1) ZA200901702B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101522171A (zh) 2006-09-28 2009-09-02 爱尔康研究有限公司 自身防腐的水性药物组合物
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
WO2013065720A1 (ja) * 2011-11-01 2013-05-10 ロート製薬株式会社 眼科用水性組成物
US20140296348A1 (en) * 2011-11-01 2014-10-02 Rohto Pharmaceutical Co., Ltd. Ophthalmological aqueous composition
EP2630952A1 (en) 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
GB201211701D0 (en) 2012-07-02 2012-08-15 Reckitt Benckiser Llc Aqueous alcoholic microbicidal compositions comprising zinc ions
GB201211702D0 (en) 2012-07-02 2012-08-15 Reckitt Benckiser Llc Sprayable aqueous alcoholic microbicidal compostions comprising zinc ions
JP6027866B2 (ja) * 2012-11-22 2016-11-16 ロート製薬株式会社 オロパタジン含有水性組成物
US9707162B2 (en) 2012-11-30 2017-07-18 Reckitt & Colman (Overseas) Limited Microbicidal personal care compositions comprising metal ions
JP6226997B2 (ja) * 2013-02-15 2017-11-08 千寿製薬株式会社 亜鉛を含有するジフルプレドナートエマルション組成物
US9693563B2 (en) 2013-08-20 2017-07-04 3M Innovative Properties Company Boron-silane polyether complex
WO2015200208A1 (en) * 2014-06-24 2015-12-30 3M Innovative Properties Company Low foaming multi enzymatic cleaner
US11458041B2 (en) 2015-10-08 2022-10-04 Ocular Therapeutix, Inc. Punctal plug and bioadhesives
AU2021215929A1 (en) 2020-02-06 2022-08-04 Ocular Therapeutix, Inc. Compositions and methods for treating ocular diseases

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2084870B (en) * 1980-10-10 1985-05-09 Muhlemann R Hans Oral compositions containing pyrimidine amine compounds and zinc salts
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
IL92351A (en) * 1988-11-29 1994-02-27 Allergan Inc Irvine Optimal aqueous solutions containing stabilized chlorine acid and inorganic salt
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
SG49774A1 (en) * 1990-12-27 1998-06-15 Allergan Inc Method and composition for disinfection contact lenses
US5460834A (en) * 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
JP3337218B2 (ja) * 1992-05-06 2002-10-21 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるホウ酸塩−ポリオール複合体の使用
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5320843A (en) * 1992-12-10 1994-06-14 Polymer Technology Corporation Method for improving antibacterial properties of ophthalmic solutions
US5736165A (en) * 1993-05-25 1998-04-07 Allergan In-the-eye use of chlorine dioxide-containing compositions
TW274516B (pl) * 1993-11-12 1996-04-21 Ciba Geigy Ag
AU3070395A (en) * 1994-07-22 1996-02-22 Alcon Laboratories, Inc. Use of low molecular weight amino acids in ophthalmic compositions
US6024954A (en) * 1994-12-12 2000-02-15 Allergan Compositions and methods for disinfecting contact lenses and preserving contact lens care products
BR9607808A (pt) * 1995-03-20 1998-07-07 Unilever Nv Composição para limpeza da pele e processo para realçar o efeito antimicrobiano das formulações para limpeza da pele
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
HU225329B1 (en) 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
AU4428397A (en) * 1996-09-20 1998-04-14 Warner-Lambert Company Oral compositions containing a zinc compound
US5820822A (en) * 1996-10-25 1998-10-13 Kross; Robert D. Antimicrobial composition and method of use
US6319464B1 (en) 1996-12-13 2001-11-20 Alcon Manufacturing, Ltd. Use of low molecular weight amino alcohols in ophthalmic compositions
US5858346A (en) * 1997-05-09 1999-01-12 Allergan Compositions and methods for enhancing contact lens wearability
CN1229110C (zh) * 1997-07-29 2005-11-30 阿尔康实验室公司 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物
US6034043A (en) * 1999-04-20 2000-03-07 Lever Brothers Company, Division Of Conopco, Inc. Mild antimicrobial liquid cleansing formulations comprising polyvalent cation or cations for improving an antimicrobial effectiveness
US6482799B1 (en) * 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
KR20030068148A (ko) * 2000-11-29 2003-08-19 노파르티스 아게 수성 소독 시스템
AR035509A1 (es) * 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
JP4863589B2 (ja) 2001-09-28 2012-01-25 ロート製薬株式会社 水性組成物
US6828356B2 (en) 2002-07-29 2004-12-07 Ast Products, Inc. Preparation of ophthalmic compositions
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
ES2323132T3 (es) * 2003-12-09 2009-07-07 Alcon, Inc. Uso de bis-aminas para incrementar la actividad antimicrobiana de composiciones acuosas.
US20050129771A1 (en) * 2003-12-11 2005-06-16 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
US20070212420A1 (en) 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
US7736744B2 (en) † 2006-09-20 2010-06-15 Ppg Industries Ohio, Inc. Aqueous resinous binders
TWI394564B (zh) 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
CN101522171A (zh) 2006-09-28 2009-09-02 爱尔康研究有限公司 自身防腐的水性药物组合物

Also Published As

Publication number Publication date
BRPI0717093A2 (pt) 2013-11-26
EP2066300B2 (en) 2019-01-23
AU2007304996A1 (en) 2008-04-10
AU2007304996B2 (en) 2013-03-21
JP2013234199A (ja) 2013-11-21
EP2066300B1 (en) 2015-06-17
EP2066300A2 (en) 2009-06-10
CA2663817A1 (en) 2008-04-10
CN101522171A (zh) 2009-09-02
WO2008042619A2 (en) 2008-04-10
JP5394927B2 (ja) 2014-01-22
PL2066300T3 (pl) 2015-10-30
MX2009003042A (es) 2009-04-02
JP2010504990A (ja) 2010-02-18
KR101421519B1 (ko) 2014-07-30
US20100021562A1 (en) 2010-01-28
WO2008042619A3 (en) 2008-07-03
ES2543349T5 (es) 2019-06-17
ES2543349T3 (es) 2015-08-18
US8388941B2 (en) 2013-03-05
KR20090066308A (ko) 2009-06-23
ZA200901702B (en) 2010-06-30
HK1126419A1 (en) 2009-09-04

Similar Documents

Publication Publication Date Title
ZA200901702B (en) Self-preserved aqueous pharmaceutical compositions
DK2068822T3 (da) Selvpræserverede vandige farmaceutiske sammensætninger
EP2001498A4 (en) PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
HK1138732A1 (en) Pharmaceutical compositions
IL188352A0 (en) Pharmaceutical compositions
ZA200804103B (en) Pharmaceutical compositions
GB0610322D0 (en) Novel pharmaceutical compositions
GB0608724D0 (en) Novel Pharmaceutical Compositions
EP2193795A4 (en) AQUEOUS PHARMACEUTICAL COMPOSITION CONTAINING LATANOPROST
GB0522045D0 (en) Pharmaceutical compositions
ZA200901164B (en) Self preserved aqueous pharmaceutical compositions
IL192091A0 (en) Pharmaceutical compositions
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
EP1845944A4 (en) PHARMACEUTICAL COMPOSITIONS
IL201912A0 (en) Aqueous pharmaceutical composition
ZA200803566B (en) Pharmaceutical compositions
GB0514259D0 (en) Pharmaceutical compositions
GB0611079D0 (en) Pharmaceutical compositions
ZA200808030B (en) Pharmaceutical compositions
GB0621623D0 (en) Pharmaceutical compositions
HU0600938D0 (en) Pharmaceutical compositions
HU0600939D0 (en) Pharmaceutical compositions
GB0622964D0 (en) Pharmaceutical compositions